FDA Post-Marketing Study Compliance Efforts To Get HHS OIG Review
Executive Summary
The HHS watchdog will also continue its look at generic drug facility inspections and supply chain oversight, according to its fiscal year 2015 work plan.
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
No comments:
Post a Comment